Cargando…

SUN-115 Distinct DNA Methylation Signature in Neuroendocrine Tumors of Different Primary Sites and Hereditary Predisposition

Objective There is scant data of the genome-wide methylome alterations in neuroendocrine tumors (NET). Thus, the goal of this study was to compare the DNA methylation signature of NETs with respect to various primary sites and inherited genetic predisposition syndromes including von Hippel-Lindau (V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tirosh, Amit, Killian, Jonathan Keith, David, Petersen, Zhu, Yuelin Jack, Blau, Jenny, Nilubol, Naris, Patel, Dhaval T, Agarwal, Sunita Kishore, Weinstein, Lee Scott, Meltzer, Paul, Kebebew, Electron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207752/ http://dx.doi.org/10.1210/jendso/bvaa046.1560

Ejemplares similares

SUN-349 Prognostic Metabolic Signature in Aggressive Adrenocortical Carcinoma
por: Tirosh, Amit, et al.
Publicado: (2019)

MON-320 Lost in the Rugae: High Grade Gastric Neuroendocrine Tumor in an MEN1 Patient with Zollinger-Ellison Syndrome
por: Bansal, Rashika, et al.
Publicado: (2019)

SUN-124 Are Venous Thromboembolic Events Increased in MEN1 Patients?
por: Lee, Maya E, et al.
Publicado: (2020)

SAT-568 Glutamine Metabolism Is a New Potential Therapeutic Target in Aggressive Thyroid Cancer
por: Patel, Dhaval, et al.
Publicado: (2019)

SUN-331 Clinical Characteristics and Genotype-Phenotype Analysis of MEN1 Patients with Thymic Neuroendocrine Tumors
por: Mandl, Adel, et al.
Publicado: (2019)

A Blood-Based Polyamine Signature Associated With Disease Progression in Patients With Multiple Endocrine Neoplasia Type 1-Related Duodenopancreatic Neuroendocrine Tumors
por: Fahrmann, Johannes F, et al.
Publicado: (2021)

SUN-116 The Role of (68)Gallium DOTATATE PET/CT Versus (18)F-FDOPA PET/CT in the Imaging of Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Tepede, Aisha, et al.
Publicado: (2020)

MON-LB055 A Single Center Experience of Multiple Endocrine Neoplasia Type 1 (MEN1) vs Sporadic Insulinoma: What Can We Learn and Where Are We Going?
por: Itatani, Miho, et al.
Publicado: (2019)

SAT-310 (18)F-FDOPA PET/CT Accurately Identifies Pheochromocytoma in 70-Year-Old Male with MEN1
por: Tepede, Aisha, et al.
Publicado: (2019)

SUN-128 Impaired Fasting Glucose Is Associated with Insulin Resistance in Patients with Germline Mutations in the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene
por: Bansal, Rashika, et al.
Publicado: (2020)

68-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor
por: Shell, Jasmine, et al.
Publicado: (2018)

Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial
por: Neychev, Vladimir, et al.
Publicado: (2015)

Somatic VHL Mutation in a Patient With MEN1-Associated Metastatic Pancreatic Neuroendocrine Tumor Responding to Sunitinib Treatment: A Case Report
por: Shell, Jasmine, et al.
Publicado: (2017)

SUN-316 Rare Neuroendocrine Tumor Presenting with Nocturnal Seizures
por: Lyerla, Ryan, et al.
Publicado: (2019)

MON-321 Metastatic Melanoma with Unknown Primary Site in a Patient with Multiple Endocrine Neoplasia Type 1
por: Kamilaris, Crystal, et al.
Publicado: (2019)

RF07 | PSUN356 Synergistic Combination of HSP90 and PI3K inhibitors in Adrenocortical Cancer
por: Mishra, Prachi, et al.
Publicado: (2022)

SUN-935 Invasive Neuroendocrine Breast Carcinoma Presenting as Liver Metastases
por: Das, Dhriti, et al.
Publicado: (2020)

Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
por: Nilubol, Naris, et al.
Publicado: (2012)

SUN-927 Ectopic Cushing Syndrome Due to a Metastatic Neuroendocrine Tumor to the Breast
por: Zhang, Jian, et al.
Publicado: (2020)

THU494 VHL Protein Deficiency Alters The Immune Microenvironment Of Pancreatic Neuroendocrine Neoplasms
por: Chmelnik, Adiel, et al.
Publicado: (2023)

Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
por: Thakur, Shilpa, et al.
Publicado: (2019)

THU508 Does Mid-treatment Response To 177Lu-DOTATATE Predict Treatment Outcome In Patients With Neuroendocrine Neoplasms?
por: Halperin, Reut, et al.
Publicado: (2023)

SUN-325 A Neuroendocrine Tumor with Liver Metastases in a patient with Acid Peptic Disease
por: López Maldonado, Francisco, et al.
Publicado: (2019)

SUN-914 Peptide Receptor Radionuclide Therapy for an Inoperable Small Cell Neuroendocrine Tumor in the Philippines
por: Alegria, Rainier Mark Gabriel
Publicado: (2020)

Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature
por: Neychev, Vladimir, et al.
Publicado: (2017)

SUN-LB057 An Interesting Case of Multiple Pancreatic Neuroendocrine Tumour: Normoglycaemic Glucagonoma and Concurrent Gastrinoma
por: Ciardi, Federico, et al.
Publicado: (2019)

THU487 Xenograft of VHL-deficient Pancreatic Neuroendocrine Neoplasm Cells - A Novel Low-grade PNEN In Vivo Model
por: Telerman, Alona, et al.
Publicado: (2023)

SUN-142 Clinical Characteristics of Patients Diagnosed with Functional Neuroendocrine Tumors Treated at a Tertiary National Referral Center in Mexico
por: Enríquez-Román, Arlette, et al.
Publicado: (2020)

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
por: Nilubol, Naris, et al.
Publicado: (2018)

Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021)

SUN-930 A Case of Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone (GHRH) Secretion from a Bronchial Neuroendocrine Tumour
por: Bahrami, Jasmine, et al.
Publicado: (2020)

SAT-115 A Rare Case of Metastatic Insulinoma in a Patient with Huntington’s Disease
por: Petrenko, Olesya, et al.
Publicado: (2020)

SUN-329 177Lu-DOTA-TATE Treatment in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors: A Single-Center 7-Year Experience
por: Gouveia, Pedro, et al.
Publicado: (2019)

SUN-938 Rare Case of Ectopic Cushing Syndrome Caused by ACTH Secreting Thymic Neuroendocrine Tumor in a Patient with Multiple Endocrine Neoplasia Type 1
por: Gorantla, Yamuna, et al.
Publicado: (2020)

SUN-907 Dual Ectopic Gastrin and ACTH Secretion Leading to Combined Zollinger-Ellison Syndrome and Cushing’s Syndrome in a Patient with Metastatic Neuroendocrine Pancreatic Tumor
por: Kwak, Leigh, et al.
Publicado: (2020)

(18)F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
por: Tepede, Aisha A, et al.
Publicado: (2020)

SUN-917 Aggressive De Novo MEN1 Variant in a Child with Metastatic Pancreatic Acth and Crh Co-Secreting Neuroendocrine Tumor: Diagnosis and 10-Year Follow Up
por: Bompou, Maria Eleni, et al.
Publicado: (2020)

SUN-313 Insulinoma: Secreting but Not Appearing
por: Patel, Sapna, et al.
Publicado: (2019)

OR23-06 Long Term Outcomes Of Parathyroid Autografts In Primary Hyperparathyroidism
por: Chuki, Elias, et al.
Publicado: (2023)

Hereditary Predisposition in Phthisis
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_i0soa0nqv0g90puf8vv7qjlq0d